KU Leuven

reMYND enters into license agreement to further develop novel treatments improving beta-cell health and insulin signalling with Novo Nordisk

Researchers from KU Leuven and the Francis Crick Institute have pinpointed 27 novel genes thought to prevent cancer from forming. Their findings could help develop personalised cancer treatments that target these genes.

KU Leuven ranks fifth in the Reuters world ranking of most innovative universities, which was published today. KU Leuven is the highest ranked non-American institution in the list. Stanford University, MIT, and Harvard score a podium finish.

Luc Sels, the new Rector of KU Leuven has selected five major projects to guide the university in the coming years